MarketWatch Automation
Shares of Gilead Sciences Inc. /zigman2/quotes/210293917/composite GILD +0.51% inched 0.39% higher to $72.37 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +2.47% rising 0.92% to 4,713.07 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.76% rising 0.51% to 36,252.02. This was the stock's second consecutive day of gains. Gilead Sciences Inc. closed $1.75 below its 52-week high ($74.12), which the company reached on December 30th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.91% fell 1.06% to $171.25, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.83% fell 0.85% to $81.67, and AbbVie Inc. /zigman2/quotes/202428675/composite ABBV -0.38% rose 0.43% to $136.97. Trading volume (8.9 M) eclipsed its 50-day average volume of 7.1 M.
Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.














